Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study | Clinical Trials | Clareo Health

Back to search

Active Not RecruitingNA

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

NCT02740634•Mayo Clinic

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more

Interventions

F-18 AV 1451

C-11 PiB

Locations

United States

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States

Key Dates

Start Date

May 1, 2016

Primary Completion Date

March 1, 2027

Completion Date

March 1, 2027

Last Updated

April 9, 2026

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators

National Institute on Aging (NIA)

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions